Clinical Scorecard: FDA issues Class I recall for Philips ultrasound
At a Glance
| Category | Detail |
|---|---|
| Condition | Philips Lumify diagnostic ultrasound system functionality issues |
| Key Mechanisms | Software may unexpectedly require transducer re-registration, which requires Wi-Fi or cellular connectivity; unstable or disconnected USB connections may interrupt imaging. |
| Target Population | Patients examined using affected Philips Lumify systems. |
| Care Setting | Point-of-care ultrasound, including ambulances, aircraft, and field settings where network access may be limited. |
Key Highlights
- The FDA classified the correction as a Class I recall on October 19, following an October 9 early alert.
- As of September 29, 2026, 8 serious injuries and 4 deaths were associated with device functionality issues.
- Unexpected transducer re-registration can prevent scanning until registration is completed using Wi-Fi or cellular connectivity.
- USB connection problems may interrupt continuous imaging and delay care.
- The recall involves updated operating instructions rather than device removal.
Guideline-Based Recommendations
Diagnosis
Management
- Philips instructed customers to use Lumify systems only where Wi-Fi or cellular connectivity is readily accessible, unless a backup ultrasound device is immediately available.
- Philips recommended maintaining alternative imaging capabilities and distributing safety notices to device users.
Monitoring & Follow-up
Risks
- Loss of ultrasound functionality may interfere with rapid diagnosis, treatment decisions, and triage of unstable patients.
- Depending on clinical circumstances, resulting delays could cause serious injury or death.
Patient & Prescribing Data
Patients examined using affected Lumify systems; the article does not provide patient-level demographic or prescribing data.
The article describes device-use precautions, not patient treatment regimens. Philips is developing a software update for unexpected re-registration and separately evaluating the USB connectivity problem.
Clinical Best Practices
- Use affected Lumify systems only where Wi-Fi or cellular connectivity is readily accessible, unless a backup ultrasound device is immediately available.
- Maintain alternative imaging capabilities.
- Distribute the safety notice to device users.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
